Scalines: novel mescaline analogues targeting 5-HT2A, 5-HT2B, 5-HT2C, and 5-HT1A receptors
O.v. Stoeckmann, S. Ostertag, D. Trachsel, M.e. Liechti, D. Rudin
Neuroscience Applied January 1, 2026 Peer reviewed DOI: 10.1016/j.nsa.2025.106565 via OpenAlex
Abstract
No abstract available from the source.